| Prev Close | 38.41 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 14.06 / 38.56 |
| Avg Volume | 3.66M |
| Exchange | |
| Shares Outstanding | 147.18M |
| Market Cap | 5.65B |
| EPS | -0.09 |
| Div & Yield | N.A. (N.A) |
Latest News
The Nominees for Best Biopharma CEO of 2015 Are...
One of these biopharma executives, or the grouped nominees, will win the Swanson Trophy, named in honor of Robert Swanson, Genentech's founding CEO. Here are the best biopharma CEOs.
Dyax Corp. Sets January 21, 2016 As Date Of Special Stockholder Meeting To Vote On Its Proposed Acquisition By Shire Plc
Dyax Corp. (NASDAQ:DYAX) ("Dyax") today announced it has set a date for a special meeting of its stockholders to consider and vote on the previously announced proposed acquisition of Dyax by Shire plc and certain other...
Dyax Corp. Presents DX-4012 Data At The 2015 American Society Of Hematology Annual Meeting
Dyax Corp. (NASDAQ: DYAX) today announced a poster presentation describing preclinical data for DX-4012, the Company's fully human monoclonal antibody to activated Factor XII (Factor XIIa), was presented at the 57th...
Market News: Avago Technologies, Dyax Corp, PVH Corp
The stock markets in the United States and other parts of the world declined today as investors were disappointed with the stimulus decision of the European Central Bank (ECB). Sign up for our free ne...
3 Drugs Stocks Moving The Industry Upward
TheStreet highlights 3 stocks pushing the drugs industry higher today.
Dyax (DYAX) Moving On Heavy Volume In The Pre-Market Hours
Trade-Ideas LLC identified Dyax (DYAX) as a pre-market mover with heavy volume candidate
OPEC Begins Meeting Today, Saudis May Cut Oil Production
Leaders of oil producing nations begin gathering in Vienna today for the OPEC meeting.
Trade-Ideas: Dyax (DYAX) Is Today's Post-Market Leader Stock
Trade-Ideas LLC identified Dyax (DYAX) as a post-market leader candidate
Dyax Corp. Announces Early Termination Of Hart-Scott-Rodino Waiting Period
Dyax Corp. (NASDAQ: DYAX) ("Dyax") today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), applicable to its proposed acquisition by Shire...
Dyax Corp. Recognized As A "Top Place To Work" By The Boston Globe For Second Year In A Row
Dyax Corp. (NASDAQ: DYAX), a biopharmaceutical company focused on the development and commercialization of novel biotherapeutics for unmet medical needs, today announced that it has been named one of the Top Places to...
'Mad Money' Lightning Round: Northrop Grumman, Lockheed Martin Both Terrific
Cramer likes Johnson & Johnson, Stryker and Edwards Lifesciences, while avoiding all Chinese stocks.
Jim Cramer's 'Mad Money' Recap: Winners Remain When Rates Rise
When interest rates begin to rise, it may be harder to find winners, Cramer said. But only a pessimist would stop looking.
DYAX CORP. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Rigrodsky & Long, P.A.
EQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Dyax Corp. That It Has Commenced An Investigation Challenging The Fairness Of The Sale Of The Company To Shire Plc
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Dyax Corp.
Dyax Corp. Presents Phase 1b DX-2930 Data At The American College Of Allergy, Asthma, And Immunology Annual Meeting
Dyax Corp. (NASDAQ:DYAX) today announced that two oral presentations describing clinical data from its DX-2930 Phase 1b study were presented at the American College of Allergy, Asthma, and Immunology (ACAAI) Annual Meeting...
INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Dyax Corp. And Encourages Investors To Contact The Firm For Additional Information
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Dyax...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Dyax Corp. (DYAX) Over The Proposed Sale Of The Company To Shire Plc.
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Dyax Corp.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Dyax Corp. Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To Shire Plc -- DYAX
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Dyax Corp.
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Dyax Corp. And Encourages Investors To Contact The Firm For Additional Information
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Dyax...
Dyax Corp. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Merger With Shire Plc
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Dyax Corp.
Stock Futures Are Edging Lower
Stock futures edge lower after Monday's rally, though remain close to all-time highs.